Interruption of Continuous Glucose Monitoring: Frequency and Adverse Consequences
Authors' conclusion
Disruption in CGM use is common. Lack of redundancy of CGM supplies contributes to care disruption and adverse glycemic events.
Study context
- Population
- Adults with T1D or T2D using continuous glucose monitoring (CGM), Diabetes Center at Washington University in St Louis; mean age 54 years, T1D 69%, female 70%, mean DM duration 28 years384 surveys sent
- Participants
- 99 adults
- Outcome
- CGM disruption events
Methodological detailssurvey, single-centre
- Survey
- Single-centre
Main finding
As reported in the abstract
- Device malfunction
- 85.4%
- Insertion problems
- 63.5%
- Falling off
- 61.4%
- Medical care-related disruption: imaging
- 41.7%
- Medical care-related disruption: surgery/procedures
- 11.7%
- Medical care-related disruption: hospitalization
- 4.4%
Observational data: associations, not effects.
Further findings
Device use
- CGM use
- 100%
- Insulin pump
- 61%
- Hybrid closed-loop (HCL) systems
- 41%
Safety
Adverse glycemic events attributed to CGM disruption, occurring ≥4 times
- Hyperglycemia ≥4 times
- 36.5%
- Hypoglycemia ≥4 times
- 12.4%
Original publication
Interruption of Continuous Glucose Monitoring: Frequency and Adverse Consequences. J Diabetes Sci Technol. Published 23 February 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →